NFKB1 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: The inflammatory process and oxidative stress downstream of dystrophin deficiency contribute to muscle pathology in DMD, with documented NF-κB activation inducing the expression of several inflammatory mediators.